Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions.

Pao W, Miller VA
J Clin Oncol. 2005 23 (11): 2556-68

PMID: 15767641 · DOI:10.1200/JCO.2005.07.799

MeSH Terms (13)

Carcinoma, Non-Small-Cell Lung Clinical Trials as Topic DNA Mutational Analysis ErbB Receptors Erlotinib Hydrochloride Gefitinib Gene Amplification Humans Lung Neoplasms Mutation Protein Kinase Inhibitors Quinazolines Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links